Trastuzumab induction of ADCC in HER2-positive breast cancer cells was observed in allograph mouse models using tumor cells of Neu/HER2-expressing mice [30] and later observed in clinical trials [27,31,32]. This evidence concerns the gene ERBB2 and breast carcinoma.